sharecast

{{ storiesRelated.title }}

Latest News
05 Feb
1561131086 cybersecurity
Falanx signs new contracts for Triarii offering, applies for CBIL

Cyber-security firm Falanx Group said on Friday that it has signed up five new customers for it its enhanced cyber-security monitoring across a range of sectors since November 2020.

05 Feb
for sale signs house prices property housing
UK house prices fall to lowest level since April 2020 in January

UK house prices dipped in January, suggesting that the recent property market boom may be slowing down.

05 Feb
french connection
French Connection in talks with two potential suitors

French Connection shares surged on Friday after the clothing retailer said it was in talks with two potential suitors.

05 Feb
electricity-meter-96863 1920-1024x768
UK energy watchdog lifts price cap for consumer bills

The UK's energy regulator is increasing its cap on consumer prices to pre-pandemic levels after a big jump in wholesale prices.

05 Feb
3757745857 ea6cb98cf8 o
German factory orders fall more than expected in December

German factory orders fell more than expected in December as coronavirus lockdowns took their toll, according to figures released by Destatis on Friday.

05 Feb
ep investigador en un laboratorio
Silence Therapeutics raises £33m to support pipeline development

Novel therapeutics developer Silence Therapeutics announced an oversubscribed private placement of 2,022,218 American depositary shares (ADSs) on Friday, raising £33m to support the development of its pipeline.

05 Feb
bourse londres london stock exchange 20200127192818
London open: Stocks tread water ahead of payrolls report

London stocks were little changed in early trade on Friday, with investors reluctant to make any big bets either way ahead of the latest US non-farm payrolls report.

05 Feb
ep laboratorio biologia molecular4
Syncona investment Achilles upbeat on safety review of trials

Healthcare investor Syncona said on Friday that its portfolio company Achilles Therapeutics, which is developing precision T-cell therapies to treat solid tumours, had announced that an independent data and safety monitoring committee had completed the first review of the ongoing, first-in-human phase 1 and 2 ‘CHIRON’ and ‘THETIS’ trials.

05 Feb
recycled containerboard warehouse mondi industrial
Warehouse REIT acquires two sites in Harlow

Real estate investment trust Warehouse REIT has acquired two adjacent distribution warehouses in Harlow.

05 Feb
lloyd's of london building, insurance, insurers.
Beazley plunges to loss on events payouts

Beazley plunged to an annual loss and paid no dividend as the Lloyd’s of London insurer was hit by $340m (£249m) of losses from the Covid-19 crisis.

05 Feb
ep on the beach travel
On the Beach warns on continued weak bookings

On the Beach said it expected holiday bookings to stay subdued into the second half of 2021 as the online vacation retailer reported tough trading caused by the Covid-19 crisis.

05 Feb
coronavirus-vaccin-astrazeneca-discute-avec-le-japon-la-russie-le-bresil-et-la-chine
AstraZeneca's Imfinzi fails to meet endpoint in cancer trial

AstraZeneca said on Friday that its Imfinzi (durvalumab) drug failed to meet its primary endpoint in a Phase III trial for head and neck cancers.

05 Feb
GIP teams up with Blackstone, Gates in $4.7bn Signature Aviation bid

Global Infrastructure Partners has teamed up with rival bidders Blackstone and Microsoft founder Bill Gates to make a $4. 73bn (£3. 43bn) bid for Signature Aviation, the companies said on Friday.

05 Feb
Beazley plunges to annual loss, Signature Aviation gets $4.7bn offer

London open The FTSE 100 is expected to open five points lower on Friday, having closed down 0. 07% on Thursday at 6,503. 72.

05 Feb
londres city brexit london 20200113130214
London pre-open: Stocks seen muted ahead of non-farm payrolls

London stocks were set for a muted open on Friday as investors eyed the latest US non-farm payrolls report.

05 Feb
noticias
Friday newspaper round-up: Johnson & Johnson, home workers, London population

Johnson & Johnson has asked US regulators to approve the world’s first single-dose Covid-19 vaccine, an easier-to-use option that could boost scarce supplies. The drugmaker’s application to the US Food and Drug Administration (FDA) follows its 29 January report in which it said the vaccine had a 66% rate of preventing infections in its large global trial. - Guardian.